Sleepmaxxing: What the Sleep Economy Is Actually Selling

By FactsFigs.com Published 02 Feb 2026

A Systematic Review Found Mouth Taping Carries a Risk of Asphyxiation

  • The Evidence (Mouth Taping): What the 2025 systematic review of mouth taping actually found.
  • The Market Claims: Market sizes quoted for the sleep optimisation industry.
  • The Inconsistency: Where those market figures fail to reconcile.
10 Studies Reviewed 2 Showed Benefit Optimising Unconsciousness PLOS One systematic review
Logo

Visual Intelligence by FactsFigs.com

PLOS One systematic review, 2025

Data Source: PLOS One

FactsFigs

Overview

Sleep optimisation has become a large consumer category, and the most useful thing to know about it concerns safety rather than spending.

Mouth taping — sealing the lips during sleep to force nasal breathing — is among the most popular practices promoted under the sleepmaxxing label. A systematic review published in PLOS One in 2025 examined ten studies and reached a cautionary conclusion.

Two studies showed statistically significant improvement in sleep apnea markers. Others showed no difference, and the review identified a serious risk: asphyxiation in people with nasal obstruction. Its conclusion was that the evidence is too limited to recommend mouth taping for unsupervised, long-term home use.

The market figures attached to this trend deserve scepticism of a different kind. The commonly quoted $137 billion total is smaller than the sum of the individual segments usually listed beneath it, which means those numbers come from incompatible sources and cannot all be describing the same market.

The Ritual With an Asphyxiation Risk

Mouth taping is presented across social media as a simple, low-cost sleep improvement — tape the lips, breathe through the nose, wake more rested. Its popularity prompted researchers to examine whether it works and whether it is safe.

The finding that matters most is the risk. In the presence of nasal obstruction, mouth taping creates a risk of asphyxiation, because it removes the airway a person was using without providing the one it assumes they have.

This is not a theoretical concern about an unusual population. Nasal obstruction is extremely common and frequently temporary — and the people most drawn to a mouth-breathing remedy are, by definition, disproportionately likely to have it.

What the Systematic Review Found

The 2025 review published in PLOS One examined ten studies covering mouth taping in patients with mouth breathing, sleep disordered breathing or obstructive sleep apnea.

Two of those studies showed statistically significant improvement in established markers of sleep apnea, including the apnea-hypopnea index and oxygen desaturations. That is a genuine positive signal and it should not be dismissed.

The remaining studies showed no difference, and several discussed potential risks. The reviewers' overall assessment was that across the available literature there is a potentially serious risk of harm for individuals indiscriminately practising the trend — with 'indiscriminately' doing the important work, distinguishing supervised clinical use from a social media recommendation applied by anyone.

Why Mouth Breathing Can Be Compensation

The logic of mouth taping assumes mouth breathing is a bad habit to be corrected. Often it is a compensation for a physical problem.

People with hay fever, a cold, a deviated septum or enlarged tonsils may breathe through the mouth because they cannot get sufficient oxygen through the nose. The mouth breathing is the body's response to an obstruction, not the cause of poor sleep.

Taping the mouth of someone in that situation does not correct a habit. It closes the functioning airway of a person whose primary one is already compromised, which is precisely the circumstance the reviewers identified as carrying asphyxiation risk.

The Second Documented Hazard

Beyond obstruction, the review identified a further risk that receives almost no attention in popular coverage: choking.

If a person regurgitates during sleep with their mouth taped shut, the normal route for clearing the airway is blocked. That is a low-probability event and a severe one, and it is elevated in anyone with reflux, or who has consumed alcohol, or who is unwell.

Together these define who should not attempt this without medical supervision: anyone with nasal congestion from any cause, structural nasal issues, reflux, or undiagnosed sleep-disordered breathing. That is a substantial share of the people the practice is marketed to.

Not Recommended for Home Use

The reviewers' conclusion was specific: the evidence is too limited to recommend mouth taping for unsupervised, long-term home use.

That wording distinguishes between contexts rather than dismissing the practice outright. In a clinical setting, with a patient whose nasal airway has been assessed and whose sleep-disordered breathing is understood, it may have a role — which is consistent with the two studies showing benefit.

Unsupervised home use by people who have not been assessed is a different proposition, and it is the one being promoted. The gap between 'showed benefit in a studied clinical population' and 'safe for anyone who saw it online' is where the identified harm sits.

The Market Numbers Don't Add Up

Turning to the economics, the figures quoted for this sector fail a basic consistency check.

The sleep economy is commonly described as $137 billion. The segments listed beneath that total typically include smart bedding at around $45 billion, sleep wearables at around $32 billion and sleep supplements or health products at around $90 billion. Those three alone sum to $167 billion — thirty billion more than the stated total for the entire market.

A breakdown cannot exceed the whole it breaks down. The only explanation is that these figures come from different research firms using different definitions, time horizons and geographic scopes, assembled into a single narrative that no single source supports.

Why Wellness Market Sizes Disagree

This is not unique to sleep. Commercial market research in consumer wellness is produced by firms selling reports, and their sizing decisions are commercially consequential — a larger addressable market makes a more compelling report.

Definitional choices do most of the work. Does a mattress count as a sleep product or as furniture? Is a smartwatch that tracks sleep a sleep device or a wearable? Do melatonin supplements belong to sleep or to the supplement category? Each answer moves the total by billions, and different firms answer differently.

The practical guidance is to treat any single wellness market figure as one firm's definitional choice rather than a measurement, and to be immediately sceptical when component figures exceed the total — as they do here.

What Actually Improves Sleep

Set against a category selling engineered solutions, the interventions with the strongest evidence base remain unglamorous and mostly free.

Consistent sleep and wake times, including at weekends, do more for sleep quality than most purchasable interventions. A cool, dark, quiet room addresses the physical conditions directly. Limiting caffeine in the afternoon and alcohol in the evening removes two well-documented disruptors — alcohol in particular reduces sleep quality even when it shortens time to falling asleep.

None of this is a reason to dismiss sleep tracking or good bedding, both of which can genuinely help. It is a reason to be clear about sequence: the basics deliver most of the available improvement, and equipment addresses what remains rather than substituting for them.

When Tracking Becomes the Problem

There is a documented failure mode in sleep optimisation where the measurement itself degrades what it measures.

Orthosomnia describes a preoccupation with achieving perfect sleep data that produces anxiety and, in turn, worse sleep. The mechanism is straightforward: sleep is the one bodily process that active effort reliably impairs. Trying harder to fall asleep does not work, and checking a score that says you slept badly supplies precisely the anxiety that makes the next night worse.

This creates an awkward position for the whole category. A tracker showing consistently good sleep tells you something you already knew from feeling rested. A tracker showing poor sleep either confirms what you felt or contradicts it — and someone who felt fine until an app told them their score was low has been made worse off by the measurement.

The reasonable use is as a trend line over weeks rather than a nightly verdict, which is roughly the opposite of how these products are designed to be checked.

Conclusion

The most important finding about sleepmaxxing is a safety one. A 2025 systematic review of ten studies concluded that mouth taping carries a potentially serious risk of harm for people practising it indiscriminately, including asphyxiation where nasal obstruction is present, and that the evidence is too limited to recommend it for unsupervised home use.

Two of those ten studies did show significant improvement in sleep apnea markers, which is why this is a question of context rather than a blanket condemnation. Assessed clinical use and a social media trend applied by anyone are different things, and the risk falls entirely on the second.

The market figures deserve equivalent scepticism. A $137 billion total with component segments summing to $167 billion cannot be describing a single market, and the discrepancy is a reliable signal that wellness sizing figures are assembled rather than measured.

This article summarises published research for general information and is not medical advice. Mouth taping should not be attempted by anyone with nasal congestion, structural nasal problems, reflux or undiagnosed sleep-disordered breathing, and anyone with persistent sleep problems should consult a qualified clinician.

Data Source and Attribution

PLOS OnePubMedEurekAlert (review coverage)

Mouth taping efficacy and safety findings come from the 2025 systematic review published in PLOS One examining mouth taping in patients with mouth breathing, sleep disordered breathing or obstructive sleep apnea, together with associated reporting on its conclusions. Market size figures are drawn from commercial market research firms as commonly quoted; these figures are internally inconsistent and are reported here to illustrate that inconsistency rather than as reliable measurements.

FactsFigs reviews, cleans, and cross-checks every source dataset before shaping it into a data story. Each visualization is created and designed in FactsFigs Design Studio — an internal tool developed and owned by FactsFigs — and is the original work of a FactsFigs author, not an AI-generated copy of any existing graphic. Individual assets within a visual may or may not be produced with AI tools, but the design of the visual itself is solely FactsFigs' own.

This content is for information only and is not medical advice, diagnosis or treatment guidance. Consult a qualified clinician about any sleep concern or before adopting any sleep intervention.

2026-07-20